Yeates A J, McSorley E M, Mulhern M S, Spence T, Crowe W, Grzesik K, Thurston S W, Watson G E, Myers G J, Davidson P W, Shamlaye C F, van Wijngaarden E, Strain J J
Nutrition Innovation Centre for Food and Health (NICHE), Ulster University, Coleraine, County Londonderry, BT52 1SA, UK.
Nutrition Innovation Centre for Food and Health (NICHE), Ulster University, Coleraine, County Londonderry, BT52 1SA, UK.
J Reprod Immunol. 2020 Feb;137:102623. doi: 10.1016/j.jri.2019.102623. Epub 2019 Oct 23.
Markers of maternal inflammation may determine infant birth outcomes.
Maternal serum samples were collected at 28 weeks gestation (n = 1418) in the Seychelles Child Development Study Nutrition Cohort 2 and analyzed for immune markers by MSD multiplex assay, including cytokines from the Th1 (IFN-γ, IL-1β, IL-2 and TNF-α) and Th2 (IL-4, IL-5, IL-10) subsets, with IL-6, MCP-1, TARC, sFlt-1 and VEGF-D. Associations of log-transformed immune markers with birthweight, length, head circumference and gestational age were assessed by multiple linear regression models, which were adjusted for maternal age, BMI, parity, child sex, gestational age and socioeconomic status.
Neither total Th1, Th2 nor Th1:Th2 were significantly associated with any birth outcome. However, the angiogenesis marker VEGF-D was predictive of a lower birthweight, (β = -0.058, P = 0.017) and birth length (β = -0.088, P = 0.001) after adjusting for covariates. Higher concentrations of CRP were predictive of a lower birthweight (β = -0.057, P = 0.023) and IL-2 (β = 0.073, P = 0.009) and the chemokine MCP-1 (β = 0.067, P = 0.016) were predictive of a longer gestational age.
In our cohort of healthy pregnant women, we found no evidence for associations between the Th1 or Th2 inflammatory markers with birth outcomes. However, VEGF-D and CRP appear to predict lower birthweight and IL-2 and MCP-1 a longer gestation. Greater understanding is required of the variation in these immune markers at different gestational stages, as well as the factors which may regulate their balance in healthy pregnancy. n = 233.
母体炎症标志物可能决定婴儿出生结局。
在塞舌尔儿童发育研究营养队列2中,于妊娠28周时收集母体血清样本(n = 1418),并通过MSD多重检测法分析免疫标志物,包括来自Th1(IFN-γ、IL-1β、IL-2和TNF-α)和Th2(IL-4、IL-5、IL-10)亚群的细胞因子,以及IL-6、MCP-1、TARC、sFlt-1和VEGF-D。通过多元线性回归模型评估经对数转换的免疫标志物与出生体重、身长、头围和孕周之间的关联,该模型对母体年龄、BMI、产次、孩子性别、孕周和社会经济状况进行了校正。
Th1、Th2总量或Th1:Th2与任何出生结局均无显著关联。然而,在调整协变量后,血管生成标志物VEGF-D可预测较低的出生体重(β = -0.058,P = 0.017)和出生身长(β = -0.088,P = 0.001)。较高浓度的CRP可预测较低的出生体重(β = -0.057,P = 0.023),IL-2(β = 0.073,P = 0.009)和趋化因子MCP-1(β = 0.067,P = 0.016)可预测较长的孕周。
在我们的健康孕妇队列中,未发现Th1或Th2炎症标志物与出生结局之间存在关联的证据。然而,VEGF-D和CRP似乎可预测较低的出生体重,而IL-2和MCP-1可预测较长的孕周。需要更深入了解这些免疫标志物在不同妊娠阶段的变化,以及可能调节其在健康妊娠中平衡的因素。n = 233。